12th Jan 2021 13:59
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 11 January 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,785,315 | 2.16% | 680,874 | 0.53% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
354,221 | 0.27% | 604,791 | 0.47% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
3,139,536 | 2.44% | 1,285,665 | 1.00% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 12 | 203.1120 USD |
Purchase | 31 | 199.8000 USD |
Purchase | 45 | 202.9550 USD |
Purchase | 74 | 199.5500 USD |
Purchase | 100 | 199.5900 USD |
Purchase | 100 | 203.5575 USD |
Purchase | 100 | 203.1100 USD |
Purchase | 100 | 203.0300 USD |
Purchase | 100 | 202.8200 USD |
Purchase | 100 | 200.3700 USD |
Purchase | 100 | 199.7600 USD |
Purchase | 116 | 203.6224 USD |
Purchase | 120 | 200.5333 USD |
Purchase | 200 | 200.5050 USD |
Purchase | 200 | 199.5950 USD |
Purchase | 202 | 199.8326 USD |
Purchase | 209 | 203.5156 USD |
Purchase | 228 | 200.5430 USD |
Purchase | 328 | 200.3384 USD |
Purchase | 351 | 199.7570 USD |
Purchase | 390 | 199.9289 USD |
Purchase | 457 | 199.9140 USD |
Purchase | 485 | 203.4359 USD |
Purchase | 520 | 200.0726 USD |
Purchase | 625 | 200.0232 USD |
Purchase | 700 | 203.5389 USD |
Purchase | 1,000 | 199.7155 USD |
Purchase | 1,010 | 199.7740 USD |
Purchase | 1,218 | 200.1866 USD |
Purchase | 3,151 | 199.2300 USD |
Purchase | 4,134 | 200.0881 USD |
Purchase | 4,242 | 200.1138 USD |
Purchase | 6,567 | 200.1119 USD |
Purchase | 6,922 | 200.0934 USD |
Purchase | 7,137 | 201.7453 USD |
Purchase | 8,422 | 199.8021 USD |
Purchase | 12,974 | 201.2478 USD |
Purchase | 18,337 | 202.4577 USD |
Purchase | 32,305 | 201.3094 USD |
Purchase | 39,748 | 203.1446 USD |
Sale | 2 | 203.4300 USD |
Sale | 11 | 202.6472 USD |
Sale | 25 | 201.4100 USD |
Sale | 45 | 202.9550 USD |
Sale | 65 | 199.5500 USD |
Sale | 100 | 202.8500 USD |
Sale | 106 | 203.0177 USD |
Sale | 122 | 202.9150 USD |
Sale | 194 | 202.6825 USD |
Sale | 198 | 203.5638 USD |
Sale | 200 | 201.7950 USD |
Sale | 200 | 203.3125 USD |
Sale | 200 | 202.9800 USD |
Sale | 259 | 202.8301 USD |
Sale | 300 | 203.3650 USD |
Sale | 425 | 202.8407 USD |
Sale | 1,256 | 203.1103 USD |
Sale | 1,927 | 203.1284 USD |
Sale | 2,902 | 202.1232 USD |
Sale | 4,242 | 200.1138 USD |
Sale | 6,712 | 201.7083 USD |
Sale | 6,717 | 201.6243 USD |
Sale | 6,792 | 200.8114 USD |
Sale | 7,229 | 199.2300 USD |
Sale | 8,542 | 203.0101 USD |
Sale | 9,136 | 203.2162 USD |
Sale | 9,586 | 203.1582 USD |
Sale | 9,822 | 203.2203 USD |
Sale | 16,213 | 202.3648 USD |
Sale | 29,693 | 201.5101 USD |
Sale | 30,000 | 199.9878 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 12 Jan 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210112005679/en/
Copyright Business Wire 2021
Related Shares:
Barclays